XTLBNasdaqPharmaceutical Preparations
XTL BIOPHARMACEUTICALS LTD
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 30, 2026
$1.96−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 946M shares
Institutional holders
3
1 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XTLB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Rhumbline Advisers | 6,228 | 0.00% | $17.00K | +241 | 0.00% |
| GAMMA Investing LLC | 1,213 | 0.00% | $3.31K | −2,175 | 0.00% |
| UBS Group AG | 125 | 0.00% | $341 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 3 | 0M | 0.0% | 1 / 1 | 1 / 4 | 0M | 0M |
| Q1 2026 | 6 | 0M | 0.0% | 6 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of XTLB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 2,225 | 0.00% | $5.34K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -10 | -0.00% | -$27 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Fain Osnat Hillel | Director | – | – | Mar 23, 2026 |
| Niv Segal | – | – | – | Mar 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Joseph Edelman 10% owner | Nov 19, 2008 | Sale | −9,600,000 | $0.15 | $1.44M | 20,580,260 |
| Joseph Edelman 10% owner | Nov 18, 2008 | Sale | −29,740 | $0.16 | $4.76K | 3,042,820 |
| Joseph Edelman 10% owner | Nov 18, 2008 | Sale | −299,570 | $0.15 | $44.94K | 0 |
| Joseph Edelman 10% owner | Nov 18, 2008 | Sale | −24,681,360 | $0.14 | $3.46M | 32,876,710 |
| Joseph Edelman 10% owner | Nov 18, 2008 | Sale | −2,696,450 | $0.15 | $404.47K | 30,180,260 |
| Joseph Edelman 10% owner | Nov 18, 2008 | Sale | −400,000 | $0.16 | $64.00K | 2,642,820 |
| Joseph Edelman 10% owner | Nov 18, 2008 | Sale | −1,943,250 | $0.14 | $272.06K | 699,570 |
| Joseph Edelman 10% owner | Nov 18, 2008 | Sale | −400,000 | $0.15 | $60.00K | 299,570 |
| Michael Cho 10% owner | Jun 10, 2008 | Buy | +48,960 | $3.23 | $158.14K | 57,558,070 |
| Michael Cho 10% owner | Jun 10, 2008 | Buy | +2,040 | $3.23 | $6.59K | 3,072,560 |
| Advisors Llc Perceptive 10% owner | Jun 9, 2008 | Buy | +32,260 | $3.36 | $108.39K | 57,509,110 |
| Advisors Llc Perceptive 10% owner | Jun 9, 2008 | Buy | +1,340 | $3.36 | $4.50K | 3,070,520 |
| Advisors Llc Perceptive 10% owner | Jun 6, 2008 | Buy | +4,000 | $3.43 | $13.72K | 3,069,180 |
| Advisors Llc Perceptive 10% owner | Jun 6, 2008 | Buy | +96,000 | $3.43 | $329.28K | 57,476,850 |
| Advisors Llc Perceptive 10% owner | Jun 5, 2008 | Buy | +8,000 | $3.15 | $25.20K | 3,065,180 |
| Advisors Llc Perceptive 10% owner | Jun 5, 2008 | Buy | +4,000 | $3.37 | $13.48K | 3,057,180 |
| Advisors Llc Perceptive 10% owner | Jun 5, 2008 | Buy | +192,000 | $3.15 | $604.80K | 57,380,850 |
| Advisors Llc Perceptive 10% owner | Jun 5, 2008 | Buy | +96,000 | $3.37 | $323.52K | 57,188,850 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jun 4, 2008 | Buy | +24,000 | $2.99 | $71.76K | 57,092,850 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jun 4, 2008 | Buy | +1,000 | $2.99 | $2.99K | 3,053,180 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jun 3, 2008 | Buy | +16,040 | $3.03 | $48.60K | 3,052,180 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jun 3, 2008 | Buy | +384,690 | $3.03 | $1.17M | 57,068,850 |
| Advisors Llc Perceptive 10% owner | May 2, 2008 | Buy | +48,000 | $3.88 | $186.24K | 56,683,890 |
| Advisors Llc Perceptive 10% owner | May 2, 2008 | Buy | +2,000 | $3.88 | $7.76K | 3,036,140 |
| Advisors Llc Perceptive 10% owner | May 1, 2008 | Buy | +100,800 | $3.75 | $378.00K | 56,635,890 |
| Advisors Llc Perceptive 10% owner | May 1, 2008 | Buy | +4,200 | $3.75 | $15.75K | 3,034,140 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Apr 30, 2008 | Buy | +5,130 | $3.74 | $19.19K | 3,029,940 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Apr 30, 2008 | Buy | +123,240 | $3.74 | $460.92K | 56,535,090 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Apr 29, 2008 | Buy | +9,160 | $3.54 | $32.43K | 3,024,810 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Apr 29, 2008 | Buy | +220,080 | $3.54 | $779.08K | 56,441,850 |
| Joseph Edelman 10% owner | Apr 10, 2008 | Buy | +10,000 | $3.56 | $35.60K | 3,015,650 |
| Joseph Edelman 10% owner | Apr 10, 2008 | Buy | +90,000 | $3.58 | $322.20K | 56,191,770 |
| Advisors Llc Perceptive 10% owner | Apr 1, 2008 | Buy | +190,950 | $3.16 | $603.40K | 56,101,770 |
| Advisors Llc Perceptive 10% owner | Apr 1, 2008 | Buy | +90,000 | $3.16 | $284.40K | 55,910,820 |
| Advisors Llc Perceptive 10% owner | Apr 1, 2008 | Buy | +10,050 | $3.16 | $31.76K | 2,995,650 |
| Advisors Llc Perceptive 10% owner | Apr 1, 2008 | Buy | +10,000 | $3.16 | $31.60K | 3,005,650 |
| Scott Bradley 10% owner | Mar 28, 2008 | Buy | +1,250 | $2.90 | $3.63K | 2,985,600 |
| Scott Bradley 10% owner | Mar 28, 2008 | Buy | +23,750 | $2.90 | $68.88K | 55,820,820 |
| Scott Bradley 10% owner | Mar 18, 2008 | Buy | +156,350 | $3.12 | $487.81K | 55,797,070 |
| Scott Bradley 10% owner | Mar 18, 2008 | Buy | +6,650 | $3.12 | $20.75K | 2,984,350 |
| Scott Bradley 10% owner | Mar 14, 2008 | Buy | +188,000 | $3.32 | $624.16K | 55,640,720 |
| Scott Bradley 10% owner | Mar 14, 2008 | Buy | +247,220 | $3.33 | $823.24K | 55,452,720 |
| Scott Bradley 10% owner | Mar 14, 2008 | Buy | +12,000 | $3.32 | $39.84K | 2,977,700 |
| Scott Bradley 10% owner | Mar 14, 2008 | Buy | +15,780 | $3.33 | $52.55K | 2,965,700 |
| Scott Bradley 10% owner | Mar 13, 2008 | Buy | +8,820 | $3.38 | $29.81K | 2,943,920 |
| Scott Bradley 10% owner | Mar 13, 2008 | Buy | +6,000 | $3.37 | $20.22K | 2,949,920 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 13, 2008 | Buy | +94,000 | $3.37 | $316.78K | 55,205,500 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 13, 2008 | Buy | +138,180 | $3.38 | $467.05K | 55,111,500 |
| Scott Bradley 10% owner | Mar 12, 2008 | Buy | +9,000 | $3.37 | $30.33K | 2,935,100 |
| Scott Bradley 10% owner | Mar 12, 2008 | Buy | +17,400 | $3.35 | $58.29K | 2,926,100 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 12, 2008 | Buy | +141,000 | $3.37 | $475.17K | 54,700,720 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 12, 2008 | Buy | +272,600 | $3.35 | $913.21K | 54,973,320 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 11, 2008 | Buy | +30,000 | $3.31 | $99.30K | 2,896,800 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 11, 2008 | Buy | +11,900 | $3.30 | $39.27K | 2,908,700 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 11, 2008 | Buy | +470,000 | $3.31 | $1.56M | 54,452,620 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 11, 2008 | Buy | +107,100 | $3.30 | $353.43K | 54,559,720 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 10, 2008 | Buy | +470,000 | $3.15 | $1.48M | 53,587,820 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 10, 2008 | Buy | +25,200 | $3.28 | $82.66K | 2,866,800 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 10, 2008 | Buy | +30,000 | $3.15 | $94.50K | 2,841,600 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Mar 10, 2008 | Buy | +30,000 | $3.25 | $97.50K | 2,811,600 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.